To include your compound in the COVID-19 Resource Center, submit it here.

Visterra reports preclinical data for dengue fever candidate

Visterra Inc. (Cambridge, Mass.) reported preclinical data from mouse models of

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE